Systemic thrombolysis in the upper extremity deep vein thrombosis

Almost 4% of all patients with venous thrombosis have upper extremity deep vein thrombosis (UEDVT) and the incidence of UEDVT increases over time. The frequency of post-thrombotic syndrome (PTS) after UEDVT is not low and upper extremity PTS is a potentially major morbidity that adversely affects qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Roxana, Safi, Morteza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347843/
https://www.ncbi.nlm.nih.gov/pubmed/22577443
_version_ 1782232334054981632
author Sadeghi, Roxana
Safi, Morteza
author_facet Sadeghi, Roxana
Safi, Morteza
author_sort Sadeghi, Roxana
collection PubMed
description Almost 4% of all patients with venous thrombosis have upper extremity deep vein thrombosis (UEDVT) and the incidence of UEDVT increases over time. The frequency of post-thrombotic syndrome (PTS) after UEDVT is not low and upper extremity PTS is a potentially major morbidity that adversely affects quality of life, particularly if the dominant arm is involved. We discuss briefly the role of thrombolytic therapy in the treatment of upper extremity deep vein thrombosis and also the role of systemic thrombolysis in selected patients.
format Online
Article
Text
id pubmed-3347843
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-33478432012-05-10 Systemic thrombolysis in the upper extremity deep vein thrombosis Sadeghi, Roxana Safi, Morteza ARYA Atheroscler Review Article Almost 4% of all patients with venous thrombosis have upper extremity deep vein thrombosis (UEDVT) and the incidence of UEDVT increases over time. The frequency of post-thrombotic syndrome (PTS) after UEDVT is not low and upper extremity PTS is a potentially major morbidity that adversely affects quality of life, particularly if the dominant arm is involved. We discuss briefly the role of thrombolytic therapy in the treatment of upper extremity deep vein thrombosis and also the role of systemic thrombolysis in selected patients. Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2011 /pmc/articles/PMC3347843/ /pubmed/22577443 Text en © 2011 Isfahan Cardiovascular Research Center & Isfahan University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Review Article
Sadeghi, Roxana
Safi, Morteza
Systemic thrombolysis in the upper extremity deep vein thrombosis
title Systemic thrombolysis in the upper extremity deep vein thrombosis
title_full Systemic thrombolysis in the upper extremity deep vein thrombosis
title_fullStr Systemic thrombolysis in the upper extremity deep vein thrombosis
title_full_unstemmed Systemic thrombolysis in the upper extremity deep vein thrombosis
title_short Systemic thrombolysis in the upper extremity deep vein thrombosis
title_sort systemic thrombolysis in the upper extremity deep vein thrombosis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347843/
https://www.ncbi.nlm.nih.gov/pubmed/22577443
work_keys_str_mv AT sadeghiroxana systemicthrombolysisintheupperextremitydeepveinthrombosis
AT safimorteza systemicthrombolysisintheupperextremitydeepveinthrombosis

Ejemplares similares